Related Experiment Video

Updated: Jun 23, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.4K

[Mycoplasma pneumoniaeoutbreak in the Netherlands 2023-2024]

Eva Kolwijck1,2, Koen S Simons3, Niels van der Sloot4

  • 1Jeroen Bosch Ziekenhuis, Den Bosch. Afd. Medische Microbiologie.

Nederlands Tijdschrift Voor Geneeskunde
|June 18, 2024
PubMed

Insights

A nationwide Mycoplasma pneumoniae outbreak is occurring, causing severe atypical pneumonia in young patients. Early recognition of clinical symptoms is crucial for effective antibiotic treatment against this resistant bacterium.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Context:

  • Nationwide outbreak of Mycoplasma pneumoniae infections.
  • Increased hospital admissions of patients with severe clinical symptoms since Fall 2023.
  • M. pneumoniae causes atypical pneumonia, often with extra-pulmonary manifestations.

Purpose:

  • To highlight the clinical presentation of Mycoplasma pneumoniae infections during the current outbreak.
  • To discuss effective antibiotic treatment strategies for M. pneumoniae.
  • To review antibiotic policy and resistance patterns.

Summary:

  • Presents a clinical lesson on Mycoplasma pneumoniae, detailing two patient cases and characteristics of 100 admitted patients.
  • Emphasizes the bacterium's resistance to standard pneumonia antibiotics and its tendency to cause severe, atypical illness.
  • Covers diagnostic challenges, extra-pulmonary symptoms, and current antibiotic resistance trends.

Impact:

  • Aims to improve early diagnosis and management of Mycoplasma pneumoniae infections.
  • Provides insights into effective antibiotic choices and policy adjustments.
  • Contributes to understanding and combating antibiotic resistance in M. pneumoniae.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.1K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
219
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
319
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
253